{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T21:47:16Z","timestamp":1790286436429,"version":"4.1.0"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Ministry of Health, Labor and Welfare of Japan"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.jneuroim.2016.06.007","type":"journal-article","created":{"date-parts":[[2016,6,26]],"date-time":"2016-06-26T00:04:05Z","timestamp":1466899445000},"page":"24-31","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Fingolimod suppresses bone resorption in female patients with multiple sclerosis"],"prefix":"10.1016","volume":"298","author":[{"given":"Yusei","family":"Miyazaki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaaki","family":"Niino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ippei","family":"Kanazawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masako","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masanori","family":"Mizuno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shin","family":"Hisahara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiyuki","family":"Fukazawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eri","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Itaru","family":"Amino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryutaro","family":"Ochi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masakazu","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sachiko","family":"Akimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoya","family":"Minami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoto","family":"Fujiki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shizuki","family":"Doi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shun","family":"Shimohama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuo","family":"Terayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seiji","family":"Kikuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneuroim.2016.06.007_bb0005","doi-asserted-by":"crossref","first-page":"21453","DOI":"10.1074\/jbc.C200176200","article-title":"The immune modulator FTY720 targets sphingosine 1-phosphate receptors","volume":"277","author":"Brinkmann","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jneuroim.2016.06.007_bb0010","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1054\/plef.1999.0100","article-title":"Sphingolipids stimulate cell growth via MAP kinase activation in osteoblastic cells.","volume":"61","author":"Carpio","year":"1999","journal-title":"Prostaglandins Leukot. Essent. Fat. Acids"},{"key":"10.1016\/j.jneuroim.2016.06.007_bb0015","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1073\/pnas.1014154108","article-title":"FTY720 (fingolimod) efficacy in an animal model of multiple sclerosis requires astrocyte sphingosine1-phosphate receptor 1 (S1P1) modulation","volume":"108","author":"Choi","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jneuroim.2016.06.007_bb0020","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1212\/WNL.51.4.1161","article-title":"Fracture history and bone loss in patients with MS","volume":"51","author":"Cosman","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2016.06.007_bb0025","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1002\/jbmr.2047","article-title":"Effect of ONO-5334 on bone mineral density and biochemical markers of bone turnover in postmenopausal osteoporosis: 2-year results from the OCEAN study","volume":"29","author":"Eastell","year":"2014","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.jneuroim.2016.06.007_bb0030","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s002239900309","article-title":"Reduced bone mass and fat- free mass in women with multiple sclerosis: effects of ambulatory status and glucocorticoid use","volume":"61","author":"Formica","year":"1997","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/j.jneuroim.2016.06.007_bb0035","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1096\/fj.03-0910fje","article-title":"The immunosuppressant FTY720 down-regulates sphingosine 1-phosphate G protein-coupled receptors","volume":"18","author":"Gr\u00e4ler","year":"2004","journal-title":"FASEB J."},{"key":"10.1016\/j.jneuroim.2016.06.007_bb0040","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1007\/s00223-003-0155-9","article-title":"Osteoblastic cells express phospholipid receptors and phosphatases and proliferate in response to sphingosine-1-phosphate","volume":"74","author":"Grey","year":"2004","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/j.jneuroim.2016.06.007_bb0045","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1007\/s40263-014-0173-3","article-title":"Osteoporosis and multiple sclerosis: risk factors, pathophysiology, and therapeutic interventions","volume":"28","author":"Gupta","year":"2014","journal-title":"CNS Drugs"},{"key":"10.1016\/j.jneuroim.2016.06.007_bb0050","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1177\/1352458510368985","article-title":"Osteoporosis in multiple sclerosis","volume":"16","author":"Hearn","year":"2010","journal-title":"Mult. Scler."},{"key":"10.1016\/j.jneuroim.2016.06.007_bb0055","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.clim.2011.05.005","article-title":"Fingolimod in multiple sclerosis: mechanisms of action and clinical efficacy","volume":"142","author":"Ingwersen","year":"2012","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.jneuroim.2016.06.007_bb0060","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/nature07713","article-title":"Sphingosine-1-phosphate mobilizes osteoclast precursors and regulates bone homeostasis","volume":"458","author":"Ishii","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.jneuroim.2016.06.007_bb0065","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1084\/jem.20101474","article-title":"Chemorepulsion by blood S1P regulates osteoclast precursor mobilization and bone remodeling in vivo","volume":"207","author":"Ishii","year":"2010","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jneuroim.2016.06.007_bb0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/ncomms6215","article-title":"Calcitonin controls bone formation by inhibiting the release of sphingosine 1-phosphate from osteoclasts","volume":"5","author":"Keller","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jneuroim.2016.06.007_bb0075","doi-asserted-by":"crossref","first-page":"3807","DOI":"10.1210\/jc.2012-2346","article-title":"Plasma sphingosine 1-phosphate levels and the risk of vertebral fracture in postmenopausal women","volume":"97","author":"Kim","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jneuroim.2016.06.007_bb0080","doi-asserted-by":"crossref","first-page":"E1421","DOI":"10.1210\/jc.2012-1044","article-title":"Higher circulating sphingosine 1-phosphate levels are associated with lower bone mineral density and higher bone resorption marker in humans","volume":"97","author":"Lee","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jneuroim.2016.06.007_bb0085","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1126\/science.1070238","article-title":"Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists","volume":"296","author":"Mandala","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.jneuroim.2016.06.007_bb0090","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1212\/WNL.0b013e3181beece8","article-title":"A cross-sectional study of bone health in multiple sclerosis","volume":"73","author":"Marrie","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2016.06.007_bb0095","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1002\/jbmr.1475","article-title":"Odanacatib reduces bone turnover and increases bone mass in the lumbar spine of skeletally mature ovariectomized rhesus monkeys","volume":"27","author":"Masarachia","year":"2012","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.jneuroim.2016.06.007_bb0100","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1212\/WNL.0b013e31820db341","article-title":"Clinical immunology of the sphingosine 1-phosphate receptor modulator fingolimod (FTY720) in multiple sclerosis","volume":"76","author":"Mehling","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2016.06.007_bb0105","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.clim.2014.02.001","article-title":"Suppressed pro-inflammatory properties of circulating B cells in patients with multiple sclerosis treated with fingolimod, based on altered proportions of B-cell subpopulations","volume":"151","author":"Miyazaki","year":"2014","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.jneuroim.2016.06.007_bb0110","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0045703","article-title":"Bone turnover and metabolism in patients with early multiple sclerosis and prevalent bone mass deficit: a population-based case-control study","volume":"7","author":"Moen","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jneuroim.2016.06.007_bb0115","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1212\/WNL.0b013e3182242d34","article-title":"Low bone mass in newly diagnosed multiple sclerosis and clinically isolated syndrome","volume":"77","author":"Moen","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2016.06.007_bb0120","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1212\/WNL.44.9.1687","article-title":"High prevalence of vitamin D deficiency and reduced bone mass in multiple sclerosis","volume":"44","author":"Nieves","year":"1994","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2016.06.007_bb0125","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jneuroim.2012.12.005","article-title":"Fingolimod phosphate promotes the neuroprotective effects of microglia","volume":"256","author":"Noda","year":"2013","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2016.06.007_bb0130","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1172\/JCI76369","article-title":"Emerging biology of sphingosine-1-phosphate: its role in pathogenesis and therapy","volume":"125","author":"Proia","year":"2015","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jneuroim.2016.06.007_bb0135","doi-asserted-by":"crossref","first-page":"5840","DOI":"10.1038\/sj.emboj.7601430","article-title":"Sphingosine 1-phosphate as a regulator of osteoclast differentiation and osteoclast-osteoblast coupling","volume":"25","author":"Ryu","year":"2006","journal-title":"EMBO J."},{"key":"10.1016\/j.jneuroim.2016.06.007_bb0140","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.bbrc.2012.05.130","article-title":"Sphingosine 1-phosphate receptor activation enhances BMP-2-induced osteoblast differentiation","volume":"423","author":"Sato","year":"2012","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jneuroim.2016.06.007_bb0145","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1191\/1352458503ms966oa","article-title":"Bone status in multiple sclerosis: beyond corticosteroids","volume":"9","author":"T\u00fcz\u00fcn","year":"2003","journal-title":"Mult. Scler."},{"key":"10.1016\/j.jneuroim.2016.06.007_bb0150","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1191\/1352458504ms993oa","article-title":"Risk of bone loss in men with multiple sclerosis","volume":"10","author":"Weinstock-Guttman","year":"2004","journal-title":"Mult. Scler."},{"key":"10.1016\/j.jneuroim.2016.06.007_bb0155","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1177\/1352458506070605","article-title":"Interferon-\u03b2 modulates bone-associated cytokines and osteoclast precursor activity in multiple sclerosis patients","volume":"12","author":"Weinstock-Guttman","year":"2006","journal-title":"Mult. Scler."}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572816301394?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572816301394?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:27:32Z","timestamp":1759048052000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572816301394"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":31,"alternative-id":["S0165572816301394"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2016.06.007","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fingolimod suppresses bone resorption in female patients with multiple sclerosis","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2016.06.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}